SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/EBA93D235DCA73D290AA7A6D8E8928691B7E6CF4A94D5B8081E0F52F09D5B8DFC87A96C521D9F574E0338AC715472D3E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/EBA93D235DCA73D290AA7A6D8E8928691B7E6CF4A94D5B8081E0F52F09D5B8DFC87A96C521D9F574E0338AC715472D3E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/EBA93D235DCA73D290AA7A6D8E8928691B7E6CF4A94D5B8081E0F52F09D5B8DFC87A96C521D9F574E0338AC715472D3E
http://www.w3.org/2000/01/rdf-schema#comment
"Results suggest that the suppression of myasthenia gravis-associated T cell responses exerted by the dual altered peptide ligand is mediated by the CD4+CD25+ immunoregulatory T cell function."
xsd:string
http://purl.uniprot.org/uniprot/#_6340D5072D2F891F9A8682F26C6EDD9DD2C9F873FB28606F22F07BCF3987DAAAA6EC15D757C9967949E55A106B26DD1E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/EBA93D235DCA73D290AA7A6D8E8928691B7E6CF4A94D5B8081E0F52F09D5B8DFC87A96C521D9F574E0338AC715472D3E
http://purl.uniprot.org/uniprot/Q544I2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EBA93D235DCA73D290AA7A6D8E8928691B7E6CF4A94D5B8081E0F52F09D5B8DFC87A96C521D9F574E0338AC715472D3E
http://purl.uniprot.org/uniprot/#_Q544I2-mappedCitation-15677327
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EBA93D235DCA73D290AA7A6D8E8928691B7E6CF4A94D5B8081E0F52F09D5B8DFC87A96C521D9F574E0338AC715472D3E